ARTICLE | Strategy

Back to School 2010: Regulatory innovation

Back to School Issue

September 13, 2010 7:00 AM UTC

For the past five years, BioCentury's Back to School Commentary has explored facets of life sciences innovation throughout the value chain, including the economics of innovation, the drivers that define the value of innovation, the substance of innovative leadership, innovation in the face of adversity, and the changing ecosystem for innovation. But we are not yet done. It is now time to address regulatory innovation.

Regulatory innovation is the sine qua non for the global drug development enterprise to deliver on its promise, which has been created by an explosion of basic science, coupled to one of the world's most complex industrial infrastructures, and built by trillions of dollars in public and private investment over the last three decades...